Medical Properties Trust (MPT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Achieved a global settlement with Steward, regaining control and re-tenanting 17 properties, ending all exposure and claims related to Steward.
Reported a net loss of $801 million for Q3 2024 ($1.34 per share), driven by significant impairment charges and negative fair value adjustments, especially related to Steward and the international joint venture.
Completed over $2.9 billion in year-to-date asset sales and monetization transactions, including major sales such as the Utah Transaction, Prime, Dignity Health, and UCHealth properties.
Transitioned hospital operations in five markets to new operators, stabilizing facilities and ensuring continuity of patient care.
Portfolio is now more diversified, with strong performance from key tenants in the U.S. and internationally.
Financial highlights
Q3 2024 total revenues were $225.8 million, down from $306.6 million in Q3 2023.
Normalized FFO for Q3 2024 was $0.16 per share ($94 million), down from $0.38 per share year-over-year.
One-time charges included $425 million impairment of working capital loans to Steward, $183 million in real estate impairments, and $131 million in negative fair value adjustments.
Paid a quarterly dividend of $0.08 per share in Q3 2024, reduced from $0.15 per share in prior quarters.
Year-to-date, executed over $2.9 billion in asset sales and monetization transactions.
Outlook and guidance
Expects gradual resumption of cash rents from re-tenanted properties in Q1 2025, ramping to $90 million annualized by end of 2025 and $160 million by end of 2026.
Total annualized cash rent projected to exceed $1 billion once all properties are stabilized.
Short-term liquidity supported by $1.2 billion in cash and credit, with $1.2 billion of debt maturing in the next 12 months.
No material real estate acquisitions expected in the near term; focus remains on deleveraging and liquidity.
Dividend limited to $0.08/share per quarter during the Modified Covenant Period.
Latest events from Medical Properties Trust
- EBITDARM coverage up to 2.6x; Q4 NFFO $0.18/share; $1B+ cash rent targeted for 2026.MPT
Q4 202519 Feb 2026 - Q2 2025 featured narrowing losses, rising cash rents, and robust refinancing activity.MPT
Q2 202519 Feb 2026 - Q3 2025 net loss narrowed, revenues rose 5%, and $150M buyback announced.MPT
Q3 202519 Feb 2026 - Q1 2025 delivered a net loss, strong liquidity, and stable rent collections amid restructuring.MPT
Q1 202519 Feb 2026 - Q2 net loss of $320.6M driven by Steward impairments, but $2.5B+ liquidity generated YTD.MPT
Q2 20242 Feb 2026 - $5.5B in asset sales and debt refinancing strengthen liquidity despite a $4.02/share loss.MPT
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay-for-performance, and ESG progress.MPT
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and executive pay up for vote at annual meeting.MPT
Proxy Filing1 Dec 2025 - Executive pay is now tightly linked to performance, with reduced CEO compensation and new hurdles.MPT
Proxy Filing1 Dec 2025